The next generation cohort: a description of a cohort at high risk for childhood onset type 2 diabetes.


Journal

Journal of developmental origins of health and disease
ISSN: 2040-1752
Titre abrégé: J Dev Orig Health Dis
Pays: England
ID NLM: 101517692

Informations de publication

Date de publication:
02 2019
Historique:
pubmed: 7 8 2018
medline: 24 3 2020
entrez: 7 8 2018
Statut: ppublish

Résumé

Children of mothers with youth-onset (<18 years) type 2 diabetes (T2D) are at increased risk of youth-onset T2D. In Canada, the highest reported prevalence of youth-onset T2D is in First Nation youth, some of whom harbor a unique genetic predisposition HNF1α polymorphism which has been associated with age of onset and clinical presentation. To describe the characteristics of the Next Generation birth cohort (n=260) at 7-9 years (n=88) and 14-16 years of age (n=27). This is a cross-sectional study of offspring exposed in utero to T2D (Next Generation Birth Cohort). Annual assessments from age 7 include height and weight, and biochemical testing (glucose, insulin, lipids, HbA1c). Descriptive statistics were employed. χ2 tests and repeated-measures ANOVA were used to compare categorical and continuous characteristics, respectively. In total, 11.9% of the total cohort have developed T2D. Of those 14-16.9 years of age, 16.0% have developed T2D. 92% of the offspring ages 7-9 and 70.3% of offspring ages 14-16 are overweight or obese. Children had a significantly higher body mass index z-score than adolescents (2.9 v. 1.5, P=0.001). Comparing the different HNF1α genotypes (G/G wildtype, G/S heterozygote, S/S homozygote); HbA1c (GG: 5.5% v. G/S: 5.7% v. S/S: 8.8%; P=0.0052), insulin (GG: 103 v. G/S: 202; P=0.05) and T2D status (G/G: 5.7% v. G/S: 28.1% v. S/S: 72.7%; P<0.0001) were significantly different between groups. T2D is very common among adolescents of mothers with youth-onset T2D. Early childhood obesity and the HNF1α G319S allele are associated with the incidence of T2D in the Next Gen offspring.

Identifiants

pubmed: 30079854
pii: S204017441800048X
doi: 10.1017/S204017441800048X
doi:

Substances chimiques

Glycated Hemoglobin A 0
hemoglobin A1c protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

24-30

Auteurs

F Jabar (F)

1The Children's Hospital Research Institute of Manitoba.

S Colatruglio (S)

1The Children's Hospital Research Institute of Manitoba.

E Sellers (E)

1The Children's Hospital Research Institute of Manitoba.

K Kroeker (K)

3Biostatistical Consulting Unit,George and Fay Yee Centre for Healthcare Innovation.

B Wicklow (B)

1The Children's Hospital Research Institute of Manitoba.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH